Clinical trial
Gabapentin Versus Estrogen for the Treatment of Hot Flashes
NCT00276081 · University of Rochester, Other · Completed
Key facts
| NCT number | NCT00276081 |
|---|---|
| Title | Gabapentin Versus Estrogen for the Treatment of Hot Flashes |
| Official title | A Randomized Trial of Gabapentin, Estrogen and Placebo for the Treatment of Postmenopausal Hot Flashes |
| Lead sponsor | University of Rochester, Other |
| Collaborators | National Institutes of Health (NIH) NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hot Flashes |
| Intervention type | Drug |
| Interventions | Gabapentin, Estrogen and placebo administration |
| Enrollment | 60 |
| Start date | May 1, 2002 |
| Completion | Sep 1, 2004 |
| First posted | Jan 12, 2006 |
| Last update posted | Nov 28, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: